Pfizer Inc (NYSE:PFE)
| 44.26 Delayed Data As of 4:00pm ET |  -0.40 / -0.90%Today’s Change | 41.45 Today|||52-Week Range 56.32 | -13.62% Year-to-Date |
PFE Regular Dividend: PFE will begin trading ex-dividend today with a $0.41 dividend payable to shareholders of record as of 01/27/23.
Latest PFE News | Press Releases
Today’s Trading
| Previous close | 44.66 |
| Today’s open | 44.20 |
| Day’s range | 43.62 - 44.36 |
| Volume | 38,460,238 |
| Average volume (3 months) | 21,366,991 |
| Market cap | $253.2B |
Data as of 4:00pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | +128.42% |
| Earnings growth (this year) | +46.60% |
| Earnings growth (next 5 years) | -6.97% |
| Revenue growth (last year) | +93.97% |
| P/E ratio | 8.5 |
| Price/Sales | 4.15 |
| Price/Book | 3.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -0.39 | -0.26% |
| NVONovo Nordisk | -1.38 | -0.99% |
| MRKMerck | -1.70 | -1.57% |
| AZNAstraZeneca | -0.65 | -0.98% |
Data as of 4:00pm ET, 01/26/2023
Financials
| Next reporting date | January 31, 2023 |
| EPS forecast (this quarter) | $1.06 |
| Annual revenue (last year) | $81.3B |
| Annual profit (last year) | $22.1B |
| Net profit margin | 27.57% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
